Centro de Investigaciones Médicas Respiratorias (CIMER) - Chile
Somos un centro médico, dedicados a la investigación clínica de enfermedades respiratorias. Atención y seguimiento de pacientes crónicos en estudios clínicos de Fase II y III.Antonio Varas 2740, Ñuñoa, Región Metropolitana, Chile
Select an option
I am a doctor
I am a sponsor
Specializations
ASMA
EPOC
Bronquiectasias
Fibrosis pulmonar
Rinosinusitis y pólipos nasales
Our team
Medical staff
InvestigadoraRosa María Feijoó
InvestigadoraMaite Oyonarte
InvestigadoraPatricia Fernández
Francisco Delgado Pizarro
Benjamin Poblete
Fabián Vásquez
Open studies
Asthma
Study to Assess the Efficacy and Safety of Atuliflapon in Moderate-to-Severe Uncontrolled Asthma - FLASH - AstraZenecaSee more
A Dose Range-Finding Study to Assess the Efficacy and Safety of Multiple Dose Levels of AZD8630 in Adults With Uncontrolled Asthma at Risk of Exacerbations - Levante - AstraZenecaSee more
Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma - AIRLYMPUS - SanofiSee more
A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Severe Eosinophilic Asthma (EXHALE-3) - EXHALE-3 - Areteia TherapeuticsSee more
Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids - Umbriel - AstraZenecaSee more
Rhinosinusitis
A Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of Itepekimab (Anti--IL-33 mAb) in Participants With Chronic Rhinosinusitis Without Nasal Polyps - Regeneron PharmaceuticalsSee more
A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal Polyps - CEREN1 - Regeneron PharmaceuticalsSee more
Chronic obstructive pulmonary disease
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD - EMBARK - AstraZenecaSee more
